Tier 3 reports for 'SPIRONOLACTONE' and 'tablet'
Tier 3 Drug Shortages
7 reports found
| Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
|---|---|---|---|---|---|
| MINT-SPIRONOLACTONE | MINT PHARMACEUTICALS INC | 2025-12-04 | 25MG | Actual shortage | 262193 |
| MINT-SPIRONOLACTONE | MINT PHARMACEUTICALS INC | 2025-12-04 | 100MG | Actual shortage | 262196 |
| TEVA-SPIRONOLACTONE | TEVA CANADA LIMITED | 2025-10-02 | 25MG | Resolved | 260636 |
| TEVA-SPIRONOLACTONE | TEVA CANADA LIMITED | 2025-08-08 | 100MG | Resolved | 258990 |
| TEVA-SPIRONOLACTONE | TEVA CANADA LIMITED | 2025-08-08 | 25MG | Resolved | 254139 |
| ALDACTONE 100 MG | PFIZER CANADA ULC | 2025-07-17 | 100MG | Actual shortage | 177270 |
| ALDACTONE 25 MG | PFIZER CANADA ULC | 2025-07-17 | 25MG | Actual shortage | 177265 |
Showing 1 to 7 of 7
Tier 3 Drug Discontinuations
0 reports found
| Brand name | Company Name | Date Updated | Strength(s) | Status | Report ID |
|---|
Showing 1 to 0 of 0